1-9 of 9
H. Charles Manning
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer

Kristen K. Ciombor, Seong-Woo Bae, Jennifer G. Whisenant, Gregory D. Ayers, Quanhu Sheng, Todd E. Peterson, Gary T. Smith, Kangyu Lin, Saikat Chowdhury, Preeti Kanikarla Marie, Alexey Sorokin, Allison S. Cohen, Laura W. Goff, Dana B. Cardin, John Paul Shen, Scott Kopetz, Cathy Eng, Yu Shyr, Jordan Berlin, H. Charles Manning
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (8): 1437–1448.
https://doi.org/10.1158/1078-0432.CCR-24-3133
Published: 14 April 2025
View articletitled, Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer
Open the PDF for Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

TSPO-targeted PET and Optical Probes for the Detection and Localization of Premalignant and Malignant Pancreatic Lesions

Allison S. Cohen, Jun Li, Matthew R. Hight, Eliot McKinley, Allie Fu, Adria Payne, Yang Liu, Dawei Zhang, Qing Xie, Mingfeng Bai, Gregory D. Ayers, Mohammed Noor Tantawy, Jarrod A. Smith, Frank Revetta, M. Kay Washington, Chanjuan Shi, Nipun Merchant, H. Charles Manning
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (22): 5914–5925.
https://doi.org/10.1158/1078-0432.CCR-20-1214
Published: 13 November 2020
View articletitled, TSPO-targeted PET and Optical Probes for the Detection and Localization of Premalignant and Malignant Pancreatic Lesions
Open the PDF for TSPO-targeted PET and Optical Probes for the Detection and Localization of Premalignant and Malignant Pancreatic Lesions in another window
Includes: Multimedia, Supplementary data
Journal Articles

Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017

Paul Okunieff, Katherine Casey-Sawicki, Natalie A. Lockney, Bradford S. Hoppe, Heiko Enderling, Chelsea Pinnix, James Welsh, Sunil Krishnan, Greg Yothers, Martin Brown, Susan Knox, Robert Bristow, Paul Spellman, Timur Mitin, Nima Nabavizadeh, Jerry Jaboin, H. Charles Manning, Felix Feng, Susan Galbraith, Abhishek A. Solanki, Matthew M. Harkenrider, Richard Tuli, Roy H. Decker, Steven E. Finkelstein, Charles C. Hsu, Chul S. Ha, Reshma Jagsi, Dean Shumway, Megan Daly, Tony J.C. Wang, Thomas J. Fitzgerald, Fran Laurie, David T. Marshall, David Raben, Louis Constine, Charles R. Thomas, Jr, Lisa A. Kachnic
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (15): 3500–3509.
https://doi.org/10.1158/1078-0432.CCR-17-3202
Published: 31 July 2018
View articletitled, Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017
Open the PDF for Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017 in another window
Journal Articles

A high-throughput molecular imaging screen to monitor therapeutic response in vivo

H. Charles Manning, A. Coe Foutch, Natasha G. Deane, Nipun Merchant, Shelby K. Wyatt, Mingfeng Bai, Darryl J. Bornhop, Robert J. Coffey, Jr.
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19_Supplement): B77.
Published: 15 August 2014
View articletitled, A high-throughput molecular imaging screen to monitor therapeutic response in vivo
Journal Articles

A Peptide-Based Positron Emission Tomography Probe for In Vivo Detection of Caspase Activity in Apoptotic Cells

Matthew R. Hight, Yiu-Yin Cheung, Michael L. Nickels, Eric S. Dawson, Ping Zhao, Samir Saleh, Jason R. Buck, Dewei Tang, M. Kay Washington, Robert J. Coffey, H. Charles Manning
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (8): 2126–2135.
https://doi.org/10.1158/1078-0432.CCR-13-2444
Published: 15 April 2014
View articletitled, A Peptide-Based Positron Emission Tomography Probe for In Vivo Detection of Caspase Activity in Apoptotic Cells
Open the PDF for A Peptide-Based Positron Emission Tomography Probe for In Vivo Detection of Caspase Activity in Apoptotic Cells in another window
Includes: Supplementary data
Journal Articles

18FDG-PET Predicts Pharmacodynamic Response to OSI-906, a Dual IGF-1R/IR Inhibitor, in Preclinical Mouse Models of Lung Cancer

Eliot T. McKinley, Joseph E. Bugaj, Ping Zhao, Saffet Guleryuz, Christine Mantis, Prafulla C. Gokhale, Robert Wild, H. Charles Manning
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (10): 3332–3340.
https://doi.org/10.1158/1078-0432.CCR-10-2274
Published: 15 May 2011
View articletitled, 18FDG-PET Predicts Pharmacodynamic Response to OSI-906, a Dual IGF-1R/IR Inhibitor, in Preclinical Mouse Models of Lung Cancer
Open the PDF for 18FDG-PET Predicts Pharmacodynamic Response to OSI-906, a Dual IGF-1R/IR Inhibitor, in Preclinical Mouse Models of Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Inhibition of Mammalian Target of Rapamycin Is Required for Optimal Antitumor Effect of HER2 Inhibitors against HER2-Overexpressing Cancer Cells

Todd W. Miller, James T. Forbes, Chirayu Shah, Shelby K. Wyatt, H. Charles Manning, Maria G. Olivares, Violeta Sanchez, Teresa C. Dugger, Nara de Matos Granja, Archana Narasanna, Rebecca S. Cook, J. Phillip Kennedy, Craig W. Lindsley, Carlos L. Arteaga
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (23): 7266–7276.
https://doi.org/10.1158/1078-0432.CCR-09-1665
Published: 30 November 2009
View articletitled, Inhibition of Mammalian Target of Rapamycin Is Required for Optimal Antitumor Effect of HER2 Inhibitors against HER2-Overexpressing Cancer Cells
Open the PDF for Inhibition of Mammalian Target of Rapamycin Is Required for Optimal Antitumor Effect of HER2 Inhibitors against HER2-Overexpressing Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Imaging Biomarkers Predict Response to Anti-HER2 (ErbB2) Therapy in Preclinical Models of Breast Cancer

Chirayu Shah, Todd W. Miller, Shelby K. Wyatt, Eliot T. McKinley, Maria Graciela Olivares, Violeta Sanchez, Donald D. Nolting, Jason R. Buck, Ping Zhao, M. Sib Ansari, Ronald M. Baldwin, John C. Gore, Rachel Schiff, Carlos L. Arteaga, H. Charles Manning
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (14): 4712–4721.
https://doi.org/10.1158/1078-0432.CCR-08-2635
Published: 15 July 2009
View articletitled, Imaging Biomarkers Predict Response to Anti-HER2 (ErbB2) Therapy in Preclinical Models of Breast Cancer
Open the PDF for Imaging Biomarkers Predict Response to Anti-HER2 (ErbB2) Therapy in Preclinical Models of Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Molecular Imaging of Therapeutic Response to Epidermal Growth Factor Receptor Blockade in Colorectal Cancer

H. Charles Manning, Nipun B. Merchant, A. Coe Foutch, John M. Virostko, Shelby K. Wyatt, Chirayu Shah, Eliot T. McKinley, Jingping Xie, Nathan J. Mutic, M. Kay Washington, Bonnie LaFleur, Mohammed Noor Tantawy, Todd E. Peterson, M. Sib Ansari, Ronald M. Baldwin, Mace L. Rothenberg, Darryl J. Bornhop, John C. Gore, Robert J. Coffey
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (22): 7413–7422.
https://doi.org/10.1158/1078-0432.CCR-08-0239
Published: 14 November 2008
View articletitled, Molecular Imaging of Therapeutic Response to Epidermal Growth Factor Receptor Blockade in Colorectal Cancer
Open the PDF for Molecular Imaging of Therapeutic Response to Epidermal Growth Factor Receptor Blockade in Colorectal Cancer in another window
Includes: Supplementary data